大细胞神经内分泌前列腺癌：大细胞不等于小细胞。
Large Cell Neuroendocrine Prostate Cancer: Large Is Not Small.
机构信息
Robert H. Lurie Comprehensive Cancer Center; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
出版信息
Oncologist. 2024 Mar 4;29(3):185-189. doi: 10.1093/oncolo/oyad344.
Abstract
Neuroendocrine prostate cancer is complex, comprising a wide spectrum of phenotypes, which has led to very different entities being inappropriately lumped together or assumed to behave like more common entities. Elucidating subtle differences is critical for treatment decision making, as this commentary describes.
摘要
神经内分泌前列腺癌是一种复杂的疾病，包含广泛的表型谱，这导致了非常不同的实体被不恰当地归为一类，或者被认为具有更常见实体的行为。正如这篇评论所描述的，阐明细微差异对于治疗决策至关重要。
相似文献
1
Large Cell Neuroendocrine Prostate Cancer: Large Is Not Small.
Oncologist. 2024 Mar 4;29(3):185-189. doi: 10.1093/oncolo/oyad344.
2
[Management of neuroendocrine prostate carcinoma: Literature review].
Cancer Radiother. 2016 Jun;20(4):330-5. doi: 10.1016/j.canrad.2016.02.013. Epub 2016 Jun 20.
3
A 45-year-old with neuroendocrine carcinoma of the prostate.
Urology. 2013 Apr;81(4):714-6. doi: 10.1016/j.urology.2012.12.029. Epub 2013 Feb 13.
4
Large Cell Neuroendocrine Carcinoma of the Prostate: A Systematic Review and Pooled Analysis.
Urol Int. 2019;103(4):383-390. doi: 10.1159/000499883. Epub 2019 Apr 9.
5
Neuroendocrine carcinomas of the prostate and urinary bladder: a diagnostic and therapeutic challenge.
Virchows Arch. 2002 Mar;440(3):241-8. doi: 10.1007/s00428-001-0583-8. Epub 2002 Jan 29.
6
Large-cell neuroendocrine carcinoma of prostate. Case report.
Arch Esp Urol. 2013 May;66(4):368-71.
7
Neuroendocrine differentiation in prostate cancer: a sheep in wolf's clothing?
Nat Clin Pract Urol. 2006 Mar;3(3):138-44. doi: 10.1038/ncpuro0435.
8
Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectives.
Urol Int. 1999;62(3):133-8. doi: 10.1159/000030376.
9
Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract.
Cancer. 2002 Oct 1;95(7):1415-20. doi: 10.1002/cncr.10840.
10
Contemporary Incidence and Cancer Control Outcomes of Primary Neuroendocrine Prostate Cancer: A SEER Database Analysis.
Clin Genitourin Cancer. 2017 Oct;15(5):e793-e800. doi: 10.1016/j.clgc.2017.04.006. Epub 2017 Apr 13.
引用本文的文献
1
Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies.
Clin Cancer Res. 2025 Feb 3;31(3):466-478. doi: 10.1158/1078-0432.CCR-24-2061.
2
Unmasking Neuroendocrine Prostate Cancer with a Machine Learning-Driven Seven-Gene Stemness Signature That Predicts Progression.
Int J Mol Sci. 2024 Oct 22;25(21):11356. doi: 10.3390/ijms252111356.
3
Unmasking Neuroendocrine Prostate Cancer with a Machine Learning-Driven 7-Gene Stemness Signature that Predicts Progression.
medRxiv. 2024 Sep 25:2024.09.24.24314303. doi: 10.1101/2024.09.24.24314303.
本文引用的文献
1
A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer.
J Clin Invest. 2022 Nov 1;132(21):e161858. doi: 10.1172/JCI161858.
2
Deciphering the enigma of neuroendocrine prostate cancer.
J Clin Invest. 2022 Nov 1;132(21):e164611. doi: 10.1172/JCI164611.
3
Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis.
Clin Cancer Res. 2022 Mar 1;28(5):928-938. doi: 10.1158/1078-0432.CCR-21-3762.
4
Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer.
J Pathol. 2021 Dec;255(4):425-437. doi: 10.1002/path.5781. Epub 2021 Sep 23.
5
Therapy considerations in neuroendocrine prostate cancer: what next?
Endocr Relat Cancer. 2021 Jul 15;28(8):T67-T78. doi: 10.1530/ERC-21-0140.
7
Clinical Characteristics, Treatment Strategy, and Outcomes of Primary Large Cell Neuroendocrine Carcinoma of the Bladder: A Case Report and Systematic Review of the Literature.
Front Oncol. 2020 Jul 28;10:1291. doi: 10.3389/fonc.2020.01291. eCollection 2020.
8
Neuroendocrine differentiation in usual-type prostatic adenocarcinoma: Molecular characterization and clinical significance.
Prostate. 2020 Sep;80(12):1012-1023. doi: 10.1002/pros.24035. Epub 2020 Jul 10.
9
Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56.
Pathol Res Pract. 2020 Jun;216(6):152993. doi: 10.1016/j.prp.2020.152993. Epub 2020 Apr 26.
10
Urinary Tract Large Cell Neuroendocrine Carcinoma: Diagnostic, Prognostic and Therapeutic Issues.
Anticancer Res. 2020 May;40(5):2439-2447. doi: 10.21873/anticanres.14213.
Zotero 插件